Found: 102
Select item for more details and to access through your institution.
Increased CSF-decorin predicts brain pathological changes driven by Alzheimer's Aβ amyloidosis.
- Published in:
- Acta Neuropathologica Communications, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40478-022-01398-5
- By:
- Publication type:
- Article
Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers.
- Published in:
- Acta Neuropathologica Communications, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40478-021-01119-4
- By:
- Publication type:
- Article
Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases.
- Published in:
- Brain: A Journal of Neurology, 2024, v. 147, n. 7, p. 2414, doi. 10.1093/brain/awae032
- By:
- Publication type:
- Article
Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.
- Published in:
- 2020
- By:
- Publication type:
- journal article
CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 9, p. 6205, doi. 10.1002/alz.14103
- By:
- Publication type:
- Article
Post‐GWAS multiomic functional investigation of the TNIP1 locus in Alzheimer's disease highlights a potential role for GPX3.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 7, p. 5044, doi. 10.1002/alz.13848
- By:
- Publication type:
- Article
Clinical proteomic analysis across the Alzheimer's disease continuum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082938
- By:
- Publication type:
- Article
Optimal combination of CSF phosphorylated‐tau forms to predict Alzheimer's disease pathological burden as measured by PET.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082746
- By:
- Publication type:
- Article
Blood proteomics to identify AD CSF molecular subtypes.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079584
- By:
- Publication type:
- Article
Profiling amyloid‐β peptides as diagnostic biomarkers for cerebral amyloid angiopathy.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.076080
- By:
- Publication type:
- Article
Strategy for absolute quantification of phospho‐Tau epitopes in cerebrospinal fluid by mass spectrometry.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079543
- By:
- Publication type:
- Article
Investigation of the choroid plexus implication in Alzheimer's disease pathophysiology using human proteomics and mouse transcriptomics.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079553
- By:
- Publication type:
- Article
SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 4609, doi. 10.1002/alz.13042
- By:
- Publication type:
- Article
Protein disulfide isomerases as CSF biomarkers for the neuronal response to tau pathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 8, p. 3563, doi. 10.1002/alz.12978
- By:
- Publication type:
- Article
Identifying Protein Quantitative Trait Loci in the Cerebrospinal Fluid Proteome.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.059964
- By:
- Publication type:
- Article
Cerebrospinal fluid biomarker panel of synaptic dysfunction in Alzheimer's disease and other neurodegenerative disorders.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 5, p. 1775, doi. 10.1002/alz.12809
- By:
- Publication type:
- Article
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non‐Alzheimer's disease pathophysiology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 3, p. 807, doi. 10.1002/alz.12713
- By:
- Publication type:
- Article
Simultaneous Mass Spectrometric quantification of multiple p‐tau species in plasma – findings along the Alzheimer´s disease continuum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.069305
- By:
- Publication type:
- Article
Derivation of cut‐offs for plasma neurofilament light in clinical routine using healthy subjects aged between 5‐90.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.065181
- By:
- Publication type:
- Article
GMNC risk alleles in individuals with Alzheimer's disease are associated with cerebrospinal fluid concentrations of proteins involved in neuronal plasticity and blood brain barrier function.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 4, p. 1, doi. 10.1002/alz.065570
- By:
- Publication type:
- Article
Multi‐modal Analysis and Modeling of Human Neurodegenerative Disease to Reveal Disease Mechanisms and Biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 4, p. 1, doi. 10.1002/alz.061905
- By:
- Publication type:
- Article
CSF Proteome Changes Depend on APOE Genotype in Prodromal AD.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 4, p. 1, doi. 10.1002/alz.061043
- By:
- Publication type:
- Article
Choroid plexus volume is associated with levels of CSF proteins predominantly expressed by the choroid plexus in non‐demented individuals with AD pathophysiology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 3, p. 1, doi. 10.1002/alz.067517
- By:
- Publication type:
- Article
Mass spectrometric measurement of six site‐specific tau phosphorylations in CSF and blood of Alzheimer's disease patients.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055985
- By:
- Publication type:
- Article
A novel antibody‐free mass spectrometry panel of CSF biomarkers for synaptic dysfunction.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.054818
- By:
- Publication type:
- Article
Decorin is an early CSF biomarker of Alzheimer's Aβ amyloidosis.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.054474
- By:
- Publication type:
- Article
Immune protein levels in cerebrospinal fluid: Associations with memory scores across the AD spectrum.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.055451
- By:
- Publication type:
- Article
Cerebrospinal fluid proteomic profiling of individuals with prodromal Alzheimer's disease classified using two different neurodegenerative biomarkers (N) in A/T/N classification.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.053030
- By:
- Publication type:
- Article
Alzheimer's disease genetic risk variants show brain cell type‐specific associations with protein levels in cerebrospinal fluid.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, n. 3, p. 1, doi. 10.1002/alz.049531
- By:
- Publication type:
- Article
CSF proteomic profiling of mild cognitive impairment individuals with suspected non‐Alzheimer's disease pathophysiology: Developing topics.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.047247
- By:
- Publication type:
- Article
Synaptic proteins relate to memory scores in preclinical Alzheimer's disease and cognitively healthy controls depending on amyloid: Molecular and cell biology/synaptic disruption.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.046102
- By:
- Publication type:
- Article
A novel proteomics assay allows parallel quantitation of a panel of synaptic proteins in human cerebrospinal fluid: Biomarkers (non‐neuroimaging) / novel biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.042578
- By:
- Publication type:
- Article
Ultra‐performance liquid chromatography‐tandem mass spectrometry method for analysis of tau in human cerebrospinal fluid without the need of immunocapture: Biomarkers (non‐neuroimaging) / Method development and/or quality control.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.040373
- By:
- Publication type:
- Article
P4‐525: ASSOCIATION OF CSF TAU WITH HYPERPLASTICITY IN ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1515, doi. 10.1016/j.jalz.2019.08.072
- By:
- Publication type:
- Article
P2‐242: PATHOPHYSIOLOGICAL SUBTYPES OF ALZHEIMER'S DISEASE BASED ON CEREBROSPINAL FLUID PROTEOMICS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P675, doi. 10.1016/j.jalz.2019.06.2649
- By:
- Publication type:
- Article
P1‐266: COMPARISON OF A FULLY AUTOMATED BEAD‐BASED SYSTEM WITH AN ENZYME‐LINKED IMMUNOSORBENT ASSAY AND AN ELECTROCHEMILUMINESCENT ASSAY FOR MEASUREMENT OF CORE AD BIOMARKERS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P341, doi. 10.1016/j.jalz.2019.06.821
- By:
- Publication type:
- Article
O3‐14‐04: THE PROTEIN‐TO‐PEPTIDE RATIO IMPROVES THE PERFORMANCE OF MICROTUBULE‐ASSOCIATED PROTEIN TAU IN CSF AS AN ALZHEIMER BIOMARKER.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1060, doi. 10.1016/j.jalz.2018.06.2852
- By:
- Publication type:
- Article
Novel cerebrospinal fluid biomarkers correlating with shunt responsiveness in patients with idiopathic normal pressure hydrocephalus.
- Published in:
- Fluids & Barriers of the CNS, 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12987-023-00440-5
- By:
- Publication type:
- Article
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13195-020-00628-z
- By:
- Publication type:
- Article
N-TERMINAL FRAGMENT OF TAU: ASSAY DEVELOPMENT WITH IN-HOUSE CLEAVAGE-SPECIFIC ANTIBODY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P964, doi. 10.1016/j.jalz.2017.06.1294
- By:
- Publication type:
- Article
NOVEL CSF FRAGMENTS OF TAU: CANDIDATE BIOMARKERS OF ALZHEIMER’S DISEASE AND TAUOPATHIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P706, doi. 10.1016/j.jalz.2017.06.898
- By:
- Publication type:
- Article
PROTEOMIC CHANGES IN ZEBRAFISH LACKING THE AMYLOID PRECURSOR HOMOLOG, APPB, USING A HIGH-THROUGHPUT DIFFERENTIAL PROTEOMIC APPROACH.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1439, doi. 10.1016/j.jalz.2017.06.2253
- By:
- Publication type:
- Article
PLEIOTROPHIN, A NEW BIOMARKER FOR AD, IDENTIFIED USING A NOVEL STRATEGY IN CLINICAL PROTEOMICS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P960, doi. 10.1016/j.jalz.2017.06.1285
- By:
- Publication type:
- Article
LUMIPULSE® G TOTAL TAU: KEY PERFORMANCES OF A FULLY AUTOMATED CHEMILUMINESCENT IMMUNOASSAY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1512, doi. 10.1016/j.jalz.2017.07.628
- By:
- Publication type:
- Article
Round robin test on quantification of amyloid-β 1–42 in cerebrospinal fluid by mass spectrometry.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, n. 1, p. 55, doi. 10.1016/j.jalz.2015.06.1890
- By:
- Publication type:
- Article
International round robin on SRM triple quad mass spectrometric analysis of aβ42 in cerebrospinal fluid.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, p. P797, doi. 10.1016/j.jalz.2014.05.1555
- By:
- Publication type:
- Article
Cerebrospinal fluid biomarker standardization efforts
- Published in:
- 2012
- By:
- Publication type:
- Abstract
An LC-MS/MS-based method for quantification of beta-amyloid-1-38, beta-amyloid-1-40 and beta-amyloid-1-42 in the cerebrospinal fluid of Alzheimer's patients and healthy controls
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Amyloid-related biomarkers for BACE1 inhibition in cell models of Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract
An enzyme activity as a potential biomarker for Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract